Glutathione peroxidase-1 activity, atherosclerotic burden, and cardiovascular prognosis

Christine Espinola-Klein1, Hans J Rupprecht, Christoph Bickel

  • 1Medical Department II, Johannes Gutenberg-University Mainz, Germany. espinola@uni-mainz.de

Insights

Lower erythrocyte glutathione peroxidase-1 (GPX-1) activity indicates higher cardiovascular risk, especially in patients with widespread atherosclerosis. This finding highlights GPX-1 as a potential biomarker for predicting future cardiovascular events.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Preventive Cardiology

Background:

  • Erythrocyte intracellular glutathione peroxidase-1 (GPX-1) activity shows an inverse relationship with future cardiovascular events.
  • The prognostic value of GPX-1 activity in relation to the extent of atherosclerosis requires further investigation.

Purpose of the Study:

  • To assess the association between GPX-1 activity and the extent of atherosclerosis.
  • To evaluate the long-term prognostic significance of GPX-1 activity in patients with varying atherosclerotic burdens.

Main Methods:

  • Prospective study of 508 patients undergoing coronary angiography.
  • Atherosclerosis assessment in carotid and leg arteries via sonography.
  • Measurement of erythrocyte GPX-1 activity in washed erythrocytes.

Main Results:

  • GPX-1 activity showed a trend towards decrease with increasing atherosclerotic vascular beds (49.3 U/g Hb in no atherosclerosis vs. 46.0 U/g Hb in 3 beds; p=NS).
  • A significant inverse association was found between GPX-1 activity tertiles and cardiovascular events over 6.5 years (adjusted HR 2.3 for lowest vs. highest tertile; p=0.002).
  • Patients with low GPX-1 activity and multivascular atherosclerosis exhibited the highest event rate (36.9%; p <0.0001).

Conclusions:

  • Decreased red blood cell GPX-1 activity is linked to elevated cardiovascular risk.
  • The combination of low GPX-1 activity and extensive atherosclerosis signifies a particularly high risk for cardiovascular events.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...